Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management

Pain Physician

Volumn 6, Issue 2, 2003, Pages 173-178

  Manchikanti, Laxmaiah ^a   Pampati, Vidyasagar ^a   Damron, Kim S ^a   Beyer, Carla D ^a   Barnhill, Renee C ^a  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

Author keywords

Cocaine; Controlled substance agreement; Drug abuse; Illicit drugs; Licit drugs; Marijuana; Methamphetamine; Opioid abuse; Prescription controlled substances

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID DERIVATIVE; CANNABIS; COCAINE; ILLICIT DRUG; METHAMPHETAMINE; OPIATE; PHENCYCLIDINE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT;

CANNABIS ADDICTION; CLINICAL PRACTICE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG SCREENING; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; EVIDENCE BASED MEDICINE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALTH SURVEY; HUMAN; MULTIPLE DRUG ABUSE; PAIN; PRESCRIPTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBSTANCE ABUSE; URINALYSIS;

EID: 0041488733     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. 1 National Household Survey on Drug Abuse (NHSDA). DHHS Publication No. (SMA) 02-3758. Rockville, MD: Department of Health and Human Services; Substance Abuse and Mental Health Services Administration, 2002.
2. Lynskey MT, Heath AC, Bucholz KK et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289: 427-433.
3. Bachman JG, Johnston LD, O'Malley PM. Explaining recent increases in students' marijuana use: Impacts of perceived risks and disapproval, 1976 through 1996. Am J Public Health 1998; 88:887-892.
4. Reid A, Lynskey MT, Copeland J. Cannabis use among Australian youth. Aust N Z J Public Health 2000; 24:596-602.
5. Substance Abuse and Mental Health Services Administration. The DASIS Report: Marijuana treatment admissions increase: 1993-1999. Available at: http://www.samhsa.gov/oas/2k2/MJtx.pdf.
6. Sloboda Z. Drug abuse patterns in the United States. IEWG June 1999; 89-107.
7. Epidemiologic Trends in Drug Abuse Advance Report. Community Epidemiology Work Group. National Institutes of Health. National Institute on Drug Abuse. CEWG Publications, Rockville, Maryland; June 2001.
8. US National Household Survey On Drug Abuse Main Findings 1998. Department of Health and Human Services; Substance Abuse and Mental Health Services Administration, DHHS Publication No. (SMA) 00-3381. Rockville le, Maryland;2000.
9. The D.A.W.N. Report. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA); Jan 2003.
10. Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: The case of prescription drugs with abuse potential. Substance Use & Misuse 2001; 36:1275-1296.
11. Epidemiologic Trends in Drug Abuse. Community Epidemiology Work Group. In Proceedings of the Community National Institute on Drug Abuse, Volume 1, Rockville, Maryland, Dec 2001, 2002.
12. Batten HL, Prottas JM, Horgan CM et al. Drug Services Research Survey. Phase II Final Report. Submitted to the National Institute on Drug Abuse. Institute for Health Policy, Brandeis University, Waltham, MA February, 1993.
13. Substance Abuse and Mental Health Services Administration (SAMHSA). National Household Survey on Drug Abuse: Population Estimates 1995. Substance Abuse and Mental Health Services Administration. US Department of Health and Human Services, June 1996.
14. Substance Abuse and Mental Health Services Administration (SAMHSA). National Household Survey on Drug Abuse: Substance Abuse and Mental Health Services Administration. US Department of Health and Human Services, Main Findings 1994. DHHS Pub. No (SMA) 963085, September 1996.
15. The NHSDA Report. Nonmedical Use of Prescription-Type Drugs among Youths and Young Adults. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA), Jan 2003.
16. Manchikanti L, Pampati V, Damron K et al. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001; 4:358-365.
17. Polatin PB, Kinney RK, Gatchel RJ et al. Psychiatric illness and chronic low back pain: The mind and the spine - which goes first? Spine 1993; 18:66-71.
18. Chabal C, Erjavec MK, Jacobson L et al. Prescription opiate abuse in chronic pain
19. Atluri S, Sudarshan G. A screening tool to determine the risk of prescription opioid abuse among patients with chronic non-malignant pain. Pain Physician 2002; 5: 447-448.
20. Kentucky Board of Medical Licensure. Model guidelines for the use of controlled substances in pain treatment. J Ky Med Assoc 2001; 99:291-2944.
21. Manchikanti L, Brown K, Singh V. National All Schedules Prescription Electronic Reporting Act NASPER: Balancing substance abuse and medical necessity in interventional pain management. Pain Physician 2002; 5:294-319.
22. Drug trafficking in the United States. Available at: http://www.usdoj.gov/dea/concern/drug_trafficking.html.
23. Stein J. The new politics of pot. TIME; Nov 4, 2002; 56-61.
24. Cloud J. Is pot good for you? TIME, Nov 4, 2002; 62-66.
25. Nahas G. Keep Off the Grass. Middlebury, Vt: Paul Eriksson: 1990.
26. 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin: Implications for vulnerability to drug addiction. Neuropharmacology 2001; 41:118-129.
27. 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 2001; 158:259-266.
28. Fergusson DM, Lynskey MT, Horwood LJ. Patterns of cannabis use among 13-14 year old New Zealanders. N Z Med J 1993; 106:247-250.
29. Cohen H. Multiple drug use considered in the light of the stepping-stone hypothesis. Int J Addict 1972; 7:27-55.
30. Ellickson PL, Hayes RD, Bell RM. Stepping through the drug use sequence: Longitudinal scalogram analysis of initiation and regular use. J Abnorm Psychol 1992; 101: 441-451.
31. MacCoun R, Reuter P. Evaluating alternative cannabis regimes. Br J Psychiatry 2001; 178:123-128.
32. National Institute on Drug Abuse, Marijuana Infofax, October 2001.
33. Office of National Drug Control Policy, Drug Descriptions: Marijuana, May 2002.
34. National Institute on Drug Abuse, Marijuana Infofax, October 2001.
35. Office of National Drug Control Policy, Drug Descriptions: Marijuana, May 2002.
36. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998; 352:1611-1616.
37. Solowij N, Stephens RS, Roffman RA et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287:1123-1131.
38. McLellan AT, Lewis DC, O'Brien CP et al. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284:1689-1695.
39. Substance Abuse and Mental Health Services Administration. The DASIS Report: Treatment referral sources for adolescent marijuana users. Available at: http://www.samhsa.gov/oas/2k2/YouthMJtx/.pdf.
40. Kandel DB. Stages in adolescent involvement in drug use. Science 1975; 190:912-914.
41. Kandel DB, Faust R. Sequences and stages in patterns of adolescent drug use. Arch en Psychiatry 1975; 32:923-932.
42. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. J Stud Alcohol 1992; 53:447-457.
43. MacCoun R. In what sense (if any) is marijuana a gateway drug? FAS Drug Policy Analysis Bulletin, 1998; Issue 4. Available at: ttp://www.fas.drugs/issue4.htm#gateway.
44. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood, III: predictors of progression. Am J Public Health 1984; 74:673-681.
45. Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92: 279-296.
46. Fergusson DM, Horwood LJ. Does cannabis use encourage other forms of illicit drug use? Addiction 2000; 95:505-520.
47. Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence; results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1998; 10:163-173.
48. Kosterman R, Hawkins JD, Guo J et al. The dynamics of alcohol and marijuana initiation: Patterns and predictors of first use in adolescence. Am J Public Health 2000; 90: 360-366.
49. National Institute on Drug Abuse, Infofax: Crack and Cocaine, October 2001.
50. Drug Enforcement Administration, Drug Descriptions: Cocaine.
51. Substance Abuse and Mental Health Services Administration, Summary of Findings from 2000 National Household Survey on Drug Abuse, September 2001.
52. Office of National Drug Control Policy, Drug Facts: Cocaine, May 2002.
53. National Institute on Drug Abuse, Infofax. Crack and Cocaine, October 2001.
54. Office of National Drug Control Policy, Drug Facts: Cocaine, May 2002.
55. Drug Enforcement Administration. The Forms of Methamphetamine, April 2002.
56. Substance Abuse and Mental Health Services Administration, Summary of Findings from 2000 National Household Survey on Drug Abuse, September 2001.
57. Office of National Drug Control Policy, Drug Facts: Methamphetamine, May 2002.
58. National Institute on Drug Abuse, Methamphetamine: Abuse and Addiction, April 1998. What are the Effects of Methamphetamine Abuse?